Cognitive changes after parathyroidectomy in patients with secondary hyperparathyroidism

Surgery

Volumn 143, Issue 4, 2008, Pages 526-532

  Chou, Fong Fu ^a   Chen, Jin Bor ^a   Hsieh, Kun Chou ^b   Liou, Chia Wei ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ALUMINUM; CALCIUM; HEMOGLOBIN; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ALUMINUM BLOOD LEVEL; ARTICLE; AUTOTRANSPLANTATION; BLOOD LEVEL; BONE PAIN; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; COGNITION; CONTROL GROUP; CONTROLLED STUDY; DEMENTIA; DIALYSIS; EDUCATION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INSOMNIA; MALE; MINI MENTAL STATE EXAMINATION; PARATHYROIDECTOMY; PHOSPHATE BLOOD LEVEL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PRURITUS; RATING SCALE; SECONDARY HYPERPARATHYROIDISM; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TREATMENT DURATION; TREATMENT OUTCOME; WEAKNESS;

ADULT; AGED; COGNITION DISORDERS; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE; MALE; MIDDLE AGED; PARATHYROID GLANDS; PARATHYROIDECTOMY;

EID: 40949161497     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2007.11.019     Document Type: Article

References (47)

1. Kurella M., Chertow G.M., Luan J., and Yaffe K. Cognitive impairment in chronic kidney disease. J Am Geriatr Soc 52 (2004) 1863-1869
2. Kurella M., Chertow G.M., Fried L.F., et al. Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol 16 (2005) 2127-2133
3. Kurella M., Yaffe K., Shlipak M.G., Wenger N.K., and Chertow G.M. Chronic kidney disease and cognitive impairment in menopausal women. Am J Kidney Dis 45 (2005) 66-76
4. Pereira A.A., Weiner D.E., Scott T., and Sanaj M.J. Cognitive function in dialysis patients. Am J Kidney Dis 45 (2005) 448-462
5. Brickman A.M., Riba A., Bell K., et al. Longitudinal assessment of patient dependence in Alzheimer disease. Arch Neurol 59 (2002) 1304-1308
6. Romans, and Sosa J.A. Psychiatric and cognitive aspect of primary hyperparathyroidism. Curr Opin Oncol 19 (2007) 1-5
7. Prager G., Kalashek A., Kaczirek K., et al. Parathyroidectomy improved concentration and retentiveness in patients with primary hyperparathyroidism. Surgery 132 (2002) 930-936
8. Chou F.F., Chan H.M., Huang T.J., Lee C.H., and Hsu K.T. Autotransplantation of parathyroid glands into subcutaneous forearm tissue for renal parathyroidism. Surgery 124 (1998) 1-5
9. Morris J.C. The clinical dementia rating (CDR): current version and scoring rules. Neurology 43 (1993) 2412-2414
10. Sehgal A.R., Grey S.F., DeOreo P.B., and Whitehouse P.J. Prevalence, recognition, and implications of mental impairment among hemodialysis patients. Am J Kidney Dis 30 (1997) 41-49
11. Fazekas G., Fazekas F., Schmidt R., et al. Brain MRI finding and cognitive impairment in patients undergoing chronic hemodialysis treatment. J Neurol Sci 134 (1995) 83-84
12. Schmidt R., Schmidt H., Curb J.D., Masaki K., White L.R., and Launer L.J. Early inflammation and dementia: a 25-year follow-up of the Honolulu Asia aging study. Ann Neurol 52 (2002) 168-174
13. Iso H., Moriyama Y., Sato S., et al. Serum total homocysteine concentrations and risk of stoke and its subtypes in Japanese. Circulation 109 (2004) 2766-2772
14. Iuliano L. The oxidant stress hypothesis of atherogenesis. Lipids 36 Suppl (2001) S41-S44
15. Lindsberg P.J., and Grau A.J. Inflammation and infections as risk factors for ischemic stroke. Stroke 34 (2003) 2518-2532
16. Pratico D., Clark C., Liun F., Rokach J., Lee V.Y., and Trojanowski J.Q. Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch Neurol 59 (2002) 972-976
17. DeCarli C. The role of cerebral vascular disease in dementia. Neurologist 9 (2003) 123-136
18. Stewart R. Vascular dementia: a diagnosis running out of time. Br J Psychiatry 180 (2002) 152-156
19. Moroney J.T., Tang M.X., Berglund L., et al. Low-density lipoprotein cholesterol and the risk of dementia with stroke. JAMA 282 (1999) 254-260
20. Johnson W.J., McCarthy J.T., Yanagihara T., et al. Effects of recombinant human erythropoietin on cerebral and cutaneous blood flow and on blood coagulability. Kidney Int 38 (1990) 919-924
21. Jumbe N.L. Erythropoietic agents as neurotherapeutic agents: what barriers exist?. Oncology. (Williston Park) 16 (2002) 91-107
22. Sun Y., Zhou C., Polk P., Nanda A., and Zhang J.H. Mechanism of erythropoletin-induced brain protection in neonatal hypoxia-ischemia rat model. J Cereb Blood Flow Metab 24 (2004) 259-270
23. Cerami A., Brines M., Ghezzi P., Ceramic C., and Itri L.M. Neuroprotective properties of epoetin alfa. Nephrol Dial Transplant 17 Suppl (2002) 8-12
24. Fraser C.L., and Arieff A.I. Nervous system complications in uremia. Ann Intern Med 109 (1988) 143-153
25. Nissenson A., Marsh J., Brown W.S., and Wolcott D. Central nervous system function in dialysis patients: a practical approach. Semin Dial 4 (1991) 115-123
26. Altmann P., Al-Salihi F., Butter K., et al. Serum aluminum levels and erythrocyte dihydropteridine reductase activity in patients on hemodialysis. N Eng J Med 371 (1987) 80-84
27. Altmann P., Dhanesha U., Hamon C., Cunningham J., Blair J., and Marsh F. Disturbance of cerebral function of aluminum in hemodialysis patients with overt aluminum toxicity. Lancet 2 (1989) 7-12
28. Pliskin N.H., Yurk H.M., Ho L.T., and Umans J.G. Neurocognitive function in chronic hemodialysis patients. Kidney Int 49 (1996) 1435-1440
29. Hickie I., Scott E., Mitchell P., Wilhelm K., Austin M.P., and Bennett B. Subcortical hyperintensity on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry 37 (1995) 151-160
30. Simpson S., Talbot P.R., Snowden J.S., and Near D. Subcortical vascular disease in elderly patients with treatment resistant depression. J Neurol Neurosurg Psychiatry 62 (1997) 196-197
31. Hickie I., Scott E., Wilhelm K., and Brodaty H. Subcortical hyperintensities on magnetic resonance imaging in patients with severe depression-a longitudinal evaluation. Biol Psychiatry 42 (1997) 367-374
32. Manley H.J., McClaran M.L., Overbay D.K., et al. Factors associated with medication-related problems in ambulatory hemodialysis patients. Am J Kidney Dis 41 (2003) 386-393
33. Kaplan B., Mason N.A., Shimp L.A., and Ascione F.J. Chronic hemodialysis patients. Part I: characterization and drug-related problems. Ann Pharmacother 28 (1994) 316-319
34. Bugge J.F. Influence of renal replacement therapy on pharmacokinetics in critically ill patients. Best Pract Res Clin Anesthesiol 18 (2004) 175-187
35. Lee H.J., Kim L., and Suh K.Y. Cognitive deterioration and changes of P300 during total sleep deprivation. Psychiatry Clin Neurosci 57 (2003) 490-496
36. Roth T., Costa e Silva J.A., and Chase M.H. Sleep and cognitive (memory) function: research and clinical perspectives. Sleep Med 2 (2001) 379-387
37. Grigoletto F., Zappala G., Anderson D.W., and Lebowitz B.D. Norms for the mini-mental state examination in a health population. Neurology 53 (1999) 315-320
38. Cagney K.A., and Lauderdale D.S. Education, wealth, and cognitive function in later life. J Gerontol B Psychol Sci Soc Sci 57 (2002) 163-172
39. Mallocy P.F., Cummings J.L., Coffey C.E., et al. Cognitive screening instruments in neuropsychiatry: a report of the committee on research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci 9 (1999) 189-197
40. Morris J.C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43 (1993) 2412-2414
41. Salinsky M.C., Storzbach D., Dodrill C.B.D., and Binder L.M. Test-retest bias, reliability, and regression equations for neuropsychological measures repeated over a 12-16-week period. J Int Neuropsychol Soc 7 (2001) 597-605
42. Zgaljardic D.J., and Benedict R.H. Evaluation of practice effects in language and spatial processing test performance. Appl Neuropsychol 8 (2001) 218-223
43. Jassal S.V., Devins G.M., Chan C.T., Bozanovic R., and Rourke S. Improvements in cognition patients converting from thrice weekly hemodialysis to nocturnal hemodialysis: a longitudinal pilot study. Kidney Int 70 (2006) 956-962
44. Kramer L., Madl C., Stockenhuber F., et al. Beneficial effect of renal transplantation on cognitive brain function. Kidney Int 49 (1996) 833-838
45. Chou F.F., Lee C.H., Chen J.B., Huang S.C., and Lee C.T. Sleep disturbances before and after parathyroidectomy for secondary hyperparathyroidism. Surgery 137 (2005) 426-430
46. Chou F.F., Lee C.H., and Chen J.B. General weakness as an indication for parathyroid surgery in patients with secondary hyperparathyroidism. Arch Surg 134 (1999) 1108-1111
47. Chou F.F., Ho J.C., Huang S.C., and Sheen-Chen S.M. A study on pruritus after parathyroidectomy for secondary hyperparathyroidism. J Am Coll Surg 190 (2000) 65-70